1. Home
  2. CLBK vs GLPG Comparison

CLBK vs GLPG Comparison

Compare CLBK & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$20.70

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$27.73

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBK
GLPG
Founded
1927
1999
Country
United States
Belgium
Employees
N/A
452
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CLBK
GLPG
Price
$20.70
$27.73
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$17.00
$36.50
AVG Volume (30 Days)
368.6K
263.2K
Earning Date
04-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
563.64
N/A
EPS
0.13
N/A
Revenue
N/A
N/A
Revenue This Year
$3.97
N/A
Revenue Next Year
$11.43
N/A
P/E Ratio
$159.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.66
$26.62
52 Week High
$21.20
$37.78

Technical Indicators

Market Signals
Indicator
CLBK
GLPG
Relative Strength Index (RSI) 64.26 36.53
Support Level $19.69 N/A
Resistance Level N/A $34.04
Average True Range (ATR) 0.39 0.56
MACD 0.02 0.08
Stochastic Oscillator 76.08 25.33

Price Performance

Historical Comparison
CLBK
GLPG

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, and it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

Share on Social Networks: